✦ LIBER ✦

Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics

✍ Scribed by Osinusi, Anuoluwapo; Meissner, Eric G.; Lee, Yu-Jin; Bon, Dimitra; Heytens, Laura; Nelson, Amy; Sneller, Michael; Kohli, Anita; Barrett, Lisa; Proschan, Michael; Herrmann, Eva; Shivakumar, Bhavana; Gu, Wenjuan; Kwan, Richard; Teferi, Geb; Talwani, Rohit; Silk, Rachel; Kotb, Colleen; Wroblewski, Susan; Fishbein, Dawn; Dewar, Robin; Highbarger, Helene; Zhang, Xiao; Kleiner, David; Wood, Brad J.; Chavez, Jose; Symonds, William T.; Subramanian, Mani; McHutchison, John; Polis, Michael A.; Fauci, Anthony S.; Masur, Henry; Kottilil, Shyamasundaran

Book ID: 120927280
Publisher: American Medical Association
Year: 2013
Tongue: English
Weight: 294 KB
Volume: 310
Category: Article
ISSN: 0098-7484
DOI: 10.1001/jama.2013.109309

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IFNL4- G Genotype Is Associated With Slo

IFNL4- G Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvir and Ribavirin

✍ Meissner, E. G.; Bon, D.; Prokunina-Olsson, L.; Tang, W.; Masur, H.; O'Brien, T. 📂 Article 📅 2013 🏛 University of Chicago Press 🌐 English ⚖ 206 KB

Cost analysis of sofosbuvir/ribavirin ve

Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals

✍ Hagan, Liesl M.; Sulkowski, Mark S.; Schinazi, Raymond F. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

Sofosbuvir for Hepatitis C Genotype 2 or

Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

✍ Jacobson, Ira M.; Gordon, Stuart C.; Kowdley, Kris V.; Yoshida, Eric M.; Rodrigu 📂 Article 📅 2013 🏛 Massachusetts Medical Society 🌐 English ⚖ 479 KB

Peginterferon and Ribavirin Treatment in

Peginterferon and Ribavirin Treatment in African American and Caucasian American Patients With Hepatitis C Genotype 1

✍ Hari S. Conjeevaram; Michael W. Fried; Lennox J. Jeffers; Norah A. Terrault; The 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Cost-effectiveness analysis of sofosbuvi

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

✍ Saab, S.; Gordon, S. C.; Park, H.; Sulkowski, M.; Ahmed, A.; Younossi, Z. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Sofosbuvir with pegylated interferon alf

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

✍ Kowdley, Kris V; Lawitz, Eric; Crespo, Israel; Hassanein, Tarek; Davis, Mitchell 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 241 KB